Asarfi Hospital P/E Ratio
Current P/E Ratio
26.98
High Valuation
High - Growth expectations or overvalued
Asarfi Hospital (ASARFI) P/E ratio is 26.98 (High), EPS (TTM) ₹8.47, current price ₹ on None — High - Growth expectations or overvalued. See Asarfi Hospital P/B valuation to compare market price against book value per share.
Current Valuation Metrics
P/E Ratio
26.98
Current Price
₹
EPS (TTM)
₹8.47
Exchange
None
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
112.69
Sector Median
44.49
Sector Rank
#11 of 57
Sector Percentile
19.3%
Earnings Breakdown (TTM)
TTM EPS
₹7.53
Mar 2026
₹1.99
Sept 2025
₹2.13
ASARFI P/E Ratio — Valuation Signal & Historical Context
Asarfi Hospital P/E 26.98 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Asarfi Hospital screener.
- Stock appears overvalued with PE of 26.98, suggesting caution for new investments
- Trading at discount to sector average PE of 112.69
ASARFI vs Healthcare Services Peers — P/E Ratio Comparison
Asarfi Hospital P/E 26.98 vs Healthcare Services average 112.69, median 44.49 — range 8.88–3151.25.
Sector Average
112.69
Sector Median
44.49
Lowest P/E
8.88
Highest P/E
3151.25
Companies
57
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 8.88 | ₹171 | Low |
| Shanmuga Hospital | SHANMUGA | 11.52 | ₹47 | Low |
| Nidan Labs & Healthcare | NIDAN | 12.13 | ₹19 | Low |
| Abate AS Industries | ABATEAS | 12.79 | ₹157 | Low |
| Deccan Health Care | DECCAN | 13.27 | ₹33 | Low |
| 3B BlackBio DX | 3BBLACKBIO | 16.64 | ₹1,007 | Moderate |
| Sangani Hospitals | SANGANI | 16.86 | ₹62 | Moderate |
| Invicta Diagnostic | INVICTA | 17.27 | ₹87 | Moderate |
| One Global Service Provi… | ONEGLOBAL | 17.27 | ₹1,140 | Moderate |
| Krsnaa Diagnostics | KRSNAA | 17.27 | ₹1,764 | Moderate |